Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

Molecular Biosystems' Optison reclassified as drug

July 30, 1997

FDA to regulate ultrasound contrast agents as drugs

July 30, 1997

Human Genome Sciences and SmithKline Beecham modify diagnostic agreement

July 28, 1997

Positive results reported for MRSA test

July 24, 1997

Cortecs and Astra promotion agreement for Helisal One Step

July 24, 1997

Kyowa Hakko/Yoshitomi launch Imagenil in Japan

July 22, 1997

Spotlight on new drugs for cancer

July 21, 1997

Epix Medical receives milestone payment

July 18, 1997

EchoGen enters clinical trials in Japan

July 18, 1997

Geron's telomerase technology covered under U.S. patent

July 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...